Table 5 Incremental cost-effectiveness ratios of optimal package of interventions
From: Cost-effectiveness of pharmacological and psychosocial interventions for schizophrenia
Intervention(s) | Incremental cost-effectiveness ratio | Probability of ICER below | |
|---|---|---|---|
|  |  | 1 × GDP | 3 × GDP |
Risperidone | Dominant | 100% | 100% |
Add Family intervention | 1,900 | 100% | 100% |
Add clozapine to most severe one third replacing risperidone | 320,000 | 38% | 51% |